Synchronizing sales and marketing around a unified, customer-centric approach is essential for pharmaceutical companies ...
Understand how disruptive technology reshapes industries by examining key examples and discovering investment approaches for ...
Can you maybe just talk about how discussions with pharma customers have been trending so far this year, particularly as interest in AI appears to be evolving? And I am curious where de-identified ...
In a market where growth is harder to generate, investors must become more selective about where they deploy capital.​ ...
Net sales projected at $2.9 billion to $2.95 billion, adjusted EBITDA of $340 million to $360 million, and adjusted EPS of $5 ...
Legal in most scenarios, the practice exploits data-driven consumer segmentation and can exacerbate inequality. Common ...
Stephen will start by reviewing our results and provide an update on the business, and Elizabeth J. Boland will follow with a more detailed review of the numbers before we open up to your questions.
The artificial intelligence era is widening the gap between winners and laggards, and the delta is not only determined by who ...
At this time, I would like to welcome everyone to Atkore's Second Quarter Fiscal Year 2026 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. Thank you ...
Consolidated operating income -- $20.7 million, a reversal from a $52.8 million operating loss in fiscal first quarter ended ...
Good day, ladies and gentlemen, and welcome to Repligen Corporation's First Quarter 2026 Earnings Conference Call. My name is Samantha, and I will be your coordinator. [Operator Instructions] I will ...
According to the JD Power Financial Services Churn Data and Analytics report, fintech brands are making meaningful inroads in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results